DrugPatentWatch Database Preview

Biogen Inc Company Profile

Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for BIOGEN INC, and what generic alternatives to BIOGEN INC drugs are available?

BIOGEN INC has two approved drugs.

There are ten US patents protecting BIOGEN INC drugs.

There are eighty-one patent family members on BIOGEN INC drugs in twenty-six countries and twenty-four supplementary protection certificates in eleven countries.

Summary for Biogen Inc

International Patents:	81
US Patents:	10
Tradenames:	2
Ingredients:	2
NDAs:	2
Patent Litigation for Biogen Inc:	See patent lawsuits for Biogen Inc
PTAB Cases with Biogen Inc as patent owner:	See PTAB cases with Biogen Inc as patent owner

Drugs and US Patents for Biogen Inc

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Biogen Inc	VUMERITY	diroximel fumarate	CAPSULE, DELAYED RELEASE;ORAL	211855-001	Oct 29, 2019		RX	Yes	Yes	8,669,281		Y	Y
Biogen Inc	TECFIDERA	dimethyl fumarate	CAPSULE, DELAYED RELEASE;ORAL	204063-002	Mar 27, 2013	AB	RX	Yes	Yes	10,994,003
Biogen Inc	VUMERITY	diroximel fumarate	CAPSULE, DELAYED RELEASE;ORAL	211855-001	Oct 29, 2019		RX	Yes	Yes	10,080,733		Y	Y
Biogen Inc	TECFIDERA	dimethyl fumarate	CAPSULE, DELAYED RELEASE;ORAL	204063-002	Mar 27, 2013	AB	RX	Yes	Yes	11,007,167
Biogen Inc	TECFIDERA	dimethyl fumarate	CAPSULE, DELAYED RELEASE;ORAL	204063-002	Mar 27, 2013	AB	RX	Yes	Yes

Expired US Patents for Biogen Inc

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Biogen Inc	TECFIDERA	dimethyl fumarate	CAPSULE, DELAYED RELEASE;ORAL	204063-001	Mar 27, 2013	8,759,393
Biogen Inc	TECFIDERA	dimethyl fumarate	CAPSULE, DELAYED RELEASE;ORAL	204063-002	Mar 27, 2013	6,509,376
Biogen Inc	TECFIDERA	dimethyl fumarate	CAPSULE, DELAYED RELEASE;ORAL	204063-001	Mar 27, 2013	6,509,376
Biogen Inc	TECFIDERA	dimethyl fumarate	CAPSULE, DELAYED RELEASE;ORAL	204063-002	Mar 27, 2013	7,803,840
Biogen Inc	TECFIDERA	dimethyl fumarate	CAPSULE, DELAYED RELEASE;ORAL	204063-001	Mar 27, 2013	7,619,001

Paragraph IV (Patent) Challenges for BIOGEN INC drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Delayed-releaseCapsules	120 mg and 240 mg		2017-03-27

International Patents for Biogen Inc Drugs

Country	Patent Number	Estimated Expiration
Eurasian Patent Organization	201500926
Slovenia	2970101
South Korea	101814474
European Patent Office	3116536
Israel	252296

Supplementary Protection Certificates for Biogen Inc Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2137537	122014000069	Germany		PRODUCT NAME: DIMETHYLFUMARAT; REGISTRATION NO/DATE: EU/1/13/837/001-002 20140130
2137537	310 5015-2014	Slovakia		PRODUCT NAME: DIMETYLFUMARAT; REGISTRATION NO/DATE: EU/1/13/837/001 - EU/1/13/837/002 20140203
0526708	SPC/GB02/030	United Kingdom		PRODUCT NAME: BOSENTAN 4-(1,1-DIMETHYLETHYL)-N-(6-(2-HYDROXYETHOXY)-5-(2-METHOXYPHENOXY)-2(PYRIMIDIN-2-YL)PYRIMIDIN-4-YL)BENZENESULFONAMIDE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
1131065	1490039-3	Sweden		PRODUCT NAME: DIMETHYL FUMARATE; REG. NO/DATE: EU/1/13/837 20140130
0230742	2001C/040	Belgium		PRODUCT NAME: MONOHYDRATE DU CHLORHYDRATE DE N,N-DIMETHYL-1-4-CHLOROPHENYL)CYCLOBUTYL-3-METHYLBUTYLAMINE ET COMPOSITIONS PHARMACEUTIQUES LE CONTENANT; NAT. REGISTRTION NO/DATE: 479 IS 52 F 5 20010425; FIRST REGISTRATION: CH 54770 19990113

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Biogen Idec
• Biogen Inc
• Bioglan